Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane vs Propofol in Lung Cancer Surgery
NCT02916147Unknown
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Start
- Oct 2016
- Primary completion
- Nov 2018
- Modality
- Small Molecules
01
Overview
Randomised trial of sevoflurane in non-small cell lung carcinoma (NSCLC), sponsored by Tianjin Medical University Cancer Institute and Hospital. Primary endpoints: high mobility group nucleosome-binding protein-1 at 2 days and high mobility group proteins b1 at 2 days. Status: unknown.
02
Drugs
sevoflurane
03
Conditions
non-small cell lung carcinoma (NSCLC)
Beyond the preview
Go deeper on NCT02916147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02916147.